Proven long-term effect for Dicot’s drug candidate
Press release: Uppsala, August 24, 2021. The pharmaceutical company Dicot now releases results from its latest animal study concluding that the drug candidate LIB-01 has a longer effect on erectile function than other drugs on the market today, and that the effect increases over time. The study outcome is a significant milestone for the LIB-01 project.As previously reported Dicot is conducting animal studies in collaboration with the French contract laboratory Pelvipharm, where the drug candidate LIB-01's effect on erectile function is tested in both healthy rats and in animal disease